libaiyi
★    

China,
2018-06-28 13:47
(2923 d 00:51 ago)

Posting: # 18988
Views: 6,228
 

 How to calculate the sample size when we have 3 treatments? [Software]

Dear all,

I want to know how to calculate the sample size when there exists R, T1, T2 under 3*3 or 6*3 design?
Is there any software or R package available for statistical analysis of william design or 3*3 design when there exists R, T1, T2?

Thanks in advance.:-D
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2018-06-28 14:57
(2922 d 23:41 ago)

@ libaiyi
Posting: # 18989
Views: 5,428
 

 Sample size estimation: PowerTOST

Hi libaiyi,

❝ Is there any R package available for statistical analysis of william design or 3*3 design when there exists R, T1, T2?


The function sampleN.TOST() of package PowerTOST. After installing/attaching in the R-console or the command window of R Studio type known.designs() to see what is covered. In sampleN.TOST() use the argument design (i.e., design="3x6x3" for the six-sequence Williams’ design or design="3x3" for the Latin Square).
For low to moderate CVs sample sizes will be identical.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
d_labes
★★★

Berlin, Germany,
2018-06-28 15:30
(2922 d 23:08 ago)

@ libaiyi
Posting: # 18990
Views: 5,282
 

 Sample size for 3 treatments

Dear libaiyi,

additional to what Helmut has recommended:
Calling sampleN.TOST() with argument design="3x6x3" is appropriate if you aim for analyzing the data according to the "all at once" strategy.

If you analyze according to the "two at a time" strategy use design="2x2", the default for that argument.

Regards,

Detlew
UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
276 visitors (1 registered, 275 guests [including 20 identified bots]).
Forum time: 14:38 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5